2011
DOI: 10.1002/anie.201101655
|View full text |Cite
|
Sign up to set email alerts
|

DNA‐Controlled Bivalent Presentation of Ligands for the Estrogen Receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
66
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
10

Relationship

6
4

Authors

Journals

citations
Cited by 66 publications
(68 citation statements)
references
References 49 publications
2
66
0
Order By: Relevance
“…Using longer PEG segments not only raised the probability of the ligand and receptor binding, but also greatly increased the entropic cost through molecular conformations of the tethered chains. Usually models like the worm-like 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 A prominent example of an approach to design bivalent ligands with variable spacer length was reported by Abendrot 103 . In this study, a DNA segment was used as a spacer to precisely control the distance between the ligands matching the estrogen receptor.…”
Section: Ligand Densitymentioning
confidence: 98%
“…Using longer PEG segments not only raised the probability of the ligand and receptor binding, but also greatly increased the entropic cost through molecular conformations of the tethered chains. Usually models like the worm-like 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 A prominent example of an approach to design bivalent ligands with variable spacer length was reported by Abendrot 103 . In this study, a DNA segment was used as a spacer to precisely control the distance between the ligands matching the estrogen receptor.…”
Section: Ligand Densitymentioning
confidence: 98%
“…Building block 3, 2'-deoxy-5'-O-(4,4'-dimethoxytrityl)-5-(hepta-1,6-diyn- 1-yl)uridine, was synthesized following the reported protocol. 41,42 The azide derived neomycin (4) was synthesized as we have previously described. 39 Trifluoroacetyl protections (4) were required to avoid undesired Cu(II) complexation of the neomycin moiety upon the click conjugation.…”
Section: Synthesis Of the Building Blocks (1-4)mentioning
confidence: 99%
“…This matrix generates P, i.e, P = exp(τQ), where exp(·) denotes the matrix-exponential. [33]. Right: In multivalent ligand-receptor complexes there exist molecular micro-states which are neither completely bound nor completely unbound.…”
Section: Rebinding Effectsmentioning
confidence: 99%